Identification of a Biomarker Predictive of Evolution of Parkinson Disease
NCT03230526
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
[18F]DPA-714 PET scan
Sponsor
Nantes University Hospital